Moreover, analysis of genome-wide CRISPR screens for cancer genetic vulnerability (depmap.org) demonstrated the selective essentiality of SMARCA4 in NB cell lines, distinguishing it from most other cancers (Fig. 1A, right panel). Here, SMARCA4 is linked to neuroblastoma.